What's the difference between climacteric and period?

Climacteric


Definition:

  • (a.) Relating to a climacteric; critical.
  • (n.) A period in human life in which some great change is supposed to take place in the constitution. The critical periods are thought by some to be the years produced by multiplying 7 into the odd numbers 3, 5, 7, and 9; to which others add the 81st year.
  • (n.) Any critical period.

Example Sentences:

  • (1) The purpose of this investigation was to evaluate the relationship between climacteric status and health symptoms across age cohorts in 522 African American women aged 25-75.
  • (2) These data suggested that estrogen may be able to control the function of the autonomic nervous system in climacteric woman.
  • (3) Researchers have failed to distinguish between the spontaneous symptoms of women subject to climacteric disturbances and the sensations others admit to on questioning.
  • (4) The TAA component of CaCx common for all clinical stages, irrespective of climacteric states, was partially purified by subjecting postmeno CaCx, Stage II to gel filtration on Sephadex G-200.
  • (5) Considering in detail the results some immediate clinical and metabolic consequences come out: namely, want of Ca is prevailing in women and just in the critical age classes (20-40 and 50-59 years, that is in fertile and climacteric ages).
  • (6) Although the evidence is not conclusive, overall many sexual changes seem to occur in the climacteric years.
  • (7) The statement that the human female climacteric represents a pathologic rather than a physiologic state should not generate antagonistic counter-arguments; rather, it should be recognized as a challenge for the identification, prediction, and prevention of organic disease in the woman during the climacteric and after.
  • (8) It is argued that this differential recovery of fructose 2,6-bisphosphate undermines claims that the amount of this compound increases at the climacteric.
  • (9) It has also been shown that too low doses of ERT are able to exert therapeutical effects on some climacteric symptoms but not on bone and compounds exerting synergic actions with ERT on bone without effects on other organs could be useful.
  • (10) Bone mass, calcium and lipid metabolism, climacteric symptoms, bleeding, blood pressure, and weight changes were studied in 62 healthy postmenopausal women at 3-month intervals throughout 2 years of treatment with continuous estradiol valerate (2 mg) plus cyproterone acetate (1 mg), sequential estradiol valerate (2 mg) plus levonorgestrel (75 micrograms), or placebo.
  • (11) Risk factors (obesity, hypertension, diabetes mellitus) for endometrial cancer were found in 38% of MB and in 20% of climacteric metrorrhagia.
  • (12) Of climacteric disturbances should be spoken only after menopause.
  • (13) Climacteric symptoms and hot flushes were significantly reduced in both hormone groups compared with the placebo group.
  • (14) The endocrinological changes of the climacteric have been defined by studying the concentrations of follicle-stimulating hormone (FSH), luteinising hormone (LH), androstenedione, testosterone, oestrone, and oestradiol in 60 normal postmenopausal women of different menopausal ages.
  • (15) In climacteric syndrome in a narrow sense (i.e., dysautonomic type), each complaint may also have its specific endocrinological cause.
  • (16) Similarly, attitudes to the climacteric vary across cultural origins, especially with regard to husband-wife relationships.
  • (17) Significant changes in carbon dioxide production and oxygen consumption were still evident well into the climacteric.
  • (18) The selection criterion was the evidence of risk factors for endometrial carcinoma, climacteric bleedings (obesity, late menopause, high blood pressure, diabetes), or endometriotropic estrogen therapy in the postmenopause.
  • (19) This can be probably explained for the genital district by the hyperestrogenic situation that the climacteric woman experiences and by the promoting effect that estrogens have on the neoplastic growth.
  • (20) Our data imply that climacteric symptoms are not accompanied by changes in the production of prostacyclin and thromboxane A2.

Period


Definition:

  • (n.) A portion of time as limited and determined by some recurring phenomenon, as by the completion of a revolution of one of the heavenly bodies; a division of time, as a series of years, months, or days, in which something is completed, and ready to recommence and go on in the same order; as, the period of the sun, or the earth, or a comet.
  • (n.) A stated and recurring interval of time; more generally, an interval of time specified or left indefinite; a certain series of years, months, days, or the like; a time; a cycle; an age; an epoch; as, the period of the Roman republic.
  • (n.) One of the great divisions of geological time; as, the Tertiary period; the Glacial period. See the Chart of Geology.
  • (n.) The termination or completion of a revolution, cycle, series of events, single event, or act; hence, a limit; a bound; an end; a conclusion.
  • (n.) A complete sentence, from one full stop to another; esp., a well-proportioned, harmonious sentence.
  • (n.) The punctuation point [.] that marks the end of a complete sentence, or of an abbreviated word.
  • (n.) One of several similar sets of figures or terms usually marked by points or commas placed at regular intervals, as in numeration, in the extraction of roots, and in circulating decimals.
  • (n.) The time of the exacerbation and remission of a disease, or of the paroxysm and intermission.
  • (n.) A complete musical sentence.
  • (v. t.) To put an end to.
  • (v. i.) To come to a period; to conclude. [Obs.] "You may period upon this, that," etc.

Example Sentences:

  • (1) Without medication atypical ventricular tachycardia develops, in the author's opinion, most probably when bradycardia has persisted for a prolonged period.
  • (2) Disease stabilisation was associated with prolonged periods of comparatively high plasma levels of drug, which appeared to be determined primarily by reduced drug clearance.
  • (3) Although the mean values for all hemodynamic variables between the two placebo periods were minimally changed, the differences in individual patients were striking.
  • (4) It was shown in experiments on four dogs by the conditioned method that the period of recovery of conditioned activity after one hour ether anaesthesia tested 7 to 7.5 days.
  • (5) Under blood preservation conditions the difference of the rates of ATP-production and -consumption is the most important factor for a high ATP-level over long periods.
  • (6) No significant change occurred in the bacterial population of our hospital unit during the period of the study (more than 3 years).
  • (7) The secondary leukemia that occurred in these patients could be distinguished from the secondary leukemia that occurs after treatment with alkylating agents by the following: a shorter latency period; a predominance of monocytic or myelomonocytic features; and frequent cytogenetic abnormalities involving 11q23.
  • (8) Sixteen patients in whom schizophrenia was initially diagnosed and who were treated with fluphenazine enanthate or decanoate developed severe depression for a short period after the injection.
  • (9) During the study period four family outbreaks and seven recurrences of infection were observed.
  • (10) After a period on fat-rich diet the patient's physical fitness was increased and the recovery period after the acute load was shorter.
  • (11) During this period he developed autoimmune haemolytic anaemia, a rare complication of myelofibrosis.
  • (12) Pituitary weight, mitotic index and chromosomes were studied in male rats following a single or repeated dose of estradiol-benzoate for a total period of 210 days.
  • (13) Most thyroid hormone actions, however, appear in the perinatal period, and infants with thyroid agenesis appear normal at birth and develop normally with prompt neonatal diagnosis and treatment.
  • (14) Maximal aberration yields were observed for 2,4-diaminotoluene, 2,6-diaminotoluene and cytosine beta-D-arabinofuranoside from 17 to 21 h, eugenol from 15 to 21 h, cadmium sulfate from 15 to 24 h and 2-aminobiphenyl, from 17 to 24 h. For adriamycin at 1 microM, the % aberrant cells remained elevated throughout the period from 9 to 29 h, while small increases at 0.1 microM ADR were found only at 13 and at 25 h. For most chemicals the maximal aberration yield occurred at a different time for each concentration tested.
  • (15) Accuracy of discrimination of letters at various preselected distances was determined each session while Ortho-rater examinations were given periodically throughout training.
  • (16) During electrophysiologic study, the effect of propafenone on the effective refractory period of the accessory pathway was determined, as well as its effect during orthodromic atrioventricular (AV) reentrant tachycardia and atrial fibrillation.
  • (17) Time-series analysis and multiple-regression modeling procedures were used to characterize changes in the overall incidence rate over the study period and to describe the contribution of additional measures to the dynamics of the incidence rates.
  • (18) Throughout the period of rehabilitation, the frequent changes of a patient's condition may require a process of ongoing evaluation and appropriate adjustments in the physical therapy program.
  • (19) Anthropometric and nutritional (serum albumin and transferrin) values were normal in both groups both at the beginning and at the end of the treatment period.
  • (20) Analysis of conjugated discharges ACHs showed that they appeared predominantly periodically (87% of cases).